Page last updated: 2024-10-25

cyproheptadine and Ambulation Disorders, Neurologic

cyproheptadine has been researched along with Ambulation Disorders, Neurologic in 1 studies

Cyproheptadine: A serotonin antagonist and a histamine H1 blocker used as antipruritic, appetite stimulant, antiallergic, and for the post-gastrectomy dumping syndrome, etc.
cyproheptadine : The product resulting from the formal oxidative coupling of position 5 of 5H-dibenzo[a,d]cycloheptene with position 4 of 1-methylpiperidine resulting in the formation of a double bond between the two fragments. It is a sedating antihistamine with antimuscarinic and calcium-channel blocking actions. It is used (particularly as the hydrochloride sesquihydrate) for the relief of allergic conditions including rhinitis, conjunctivitis due to inhalant allergens and foods, urticaria and angioedema, and in pruritic skin disorders. Unlike other antihistamines, it is also a seratonin receptor antagonist, making it useful in conditions such as vascular headache and anorexia.

Research Excerpts

ExcerptRelevanceReference
"Pre-treatment with cyproheptadine also resulted in a decrease of other toxic symptoms associated with Boophone disticha."1.39Pre-treatment of BALB/c mice with a centrally acting serotonin antagonist (cyproheptadine) reduces mortality from Boophone disticha poisoning. ( Gadaga, LL; Mutseura, M; Tagwireyi, D, 2013)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mutseura, M1
Tagwireyi, D1
Gadaga, LL1

Other Studies

1 other study available for cyproheptadine and Ambulation Disorders, Neurologic

ArticleYear
Pre-treatment of BALB/c mice with a centrally acting serotonin antagonist (cyproheptadine) reduces mortality from Boophone disticha poisoning.
    Clinical toxicology (Philadelphia, Pa.), 2013, Volume: 51, Issue:1

    Topics: Africa, Southern; Animals; Behavior, Animal; Cyproheptadine; Dose-Response Relationship, Drug; Embry

2013